(Overview) The Providence/Boston Center for AIDS Research (CFAR) is composed of two academic institutions, Brown University and Boston University, their affiliated hospitals, Lifespan and Boston Medical Center (BMC), and the RI Department of Health, MA Department of Public Health, local community organizations, and international sites. The mission of the Providence/Boston CFAR is to promote the NIH HIV priority research agenda. We are devoted to the pursuit of translational research to reduce the burden of HIV infection worldwide, with special focus on substance users, women, MSM, justice-involved persons, and at-risk youth. To achieve this goal, we are committed to fostering emerging HIV investigators both domestically and within resource-limited settings. The CFAR consists of 6 Cores (Administrative, Developmental, BioBehavioral Sciences, Biostatistics, Basic and Translational Sciences, Substance Use Research), and one HIV/TB Scientific Working Group. We have a strong, dynamic group of HIV researchers from our long history, and expect continued growth from the addition of Boston University Medical Campus (BUMC) investigators. Our goal is to decrease the HIV epidemic by advancing research in prevention, treatment and its cascade, and the care of co- morbidities among the most afflicted and vulnerable populations. The Cores are strategically formed to support areas of strength among the Providence/Boston CFAR investigators. Our investigators have innovative approaches in biomedical prevention, treatment modalities, and cutting-edge research on substance use, leveraging our unique position of having an alcohol and HIV center within each institution. Our HIV in women's program has a long history of defining the natural history of HIV in women, pathogenesis, and prevention, including microbicide research. The partnership also brings research strength in economic analysis, cost- effectiveness, computational biology, and HIV/TB.

Public Health Relevance

(OVERVIEW) The Providence/Boston CFAR, a collaboration between Brown University/Lifespan and Boston University and Boston Medical Center (BUMC), has the leadership, infrastructure, and a wide range of HIV/AIDS Core services for our research community to promote the NIH HIV priority research agenda. Our CFAR is devoted to the pursuit of translational research to reduce the burden of HIV infection worldwide, with special focus on substance users, women, MSM, justice-involved persons, and at-risk youth. To achieve this goal, we are committed to fostering emerging HIV investigators both domestically and within resource-limited settings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-22
Application #
9953978
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Wong, Elaine Wai-Ken
Project Start
1998-09-01
Project End
2023-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Carroll, Jennifer J; Rich, Josiah D; Green, Traci C (2018) The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible. J Addict Med 12:459-465
Coleman, Sharon M; Gnatienko, Natalia; Lloyd-Travaglini, Christine A et al. (2018) False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. HIV Clin Trials 19:15-22
Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X et al. (2018) Zika Virus Exposure in an HIV-Infected Cohort in Ghana. J Acquir Immune Defic Syndr 78:e35-e38
N'Guessan, Kombo F; Boyce, Ceejay; Kwara, Awewura et al. (2018) Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Virus Genes 54:361-367
Freiman, J Morgan; Jacobson, Karen R; Muyindike, Winnie R et al. (2018) Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr 77:405-412
Chan, Philip A; Crowley, Christina; Rose, Jennifer S et al. (2018) A Network Analysis of Sexually Transmitted Diseases and Online Hookup Sites Among Men Who Have Sex With Men. Sex Transm Dis 45:462-468
Cook, Linda; Starr, Kimberly; Boonyaratanakornkit, Jerry et al. (2018) Does Size Matter? Comparison of Extraction Yields for Different-Sized DNA Fragments by Seven Different Routine and Four New Circulating Cell-Free Extraction Methods. J Clin Microbiol 56:
Yang, Hongmei; Enimil, Anthony; Gillani, Fizza S et al. (2018) Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children: Adequacy of Revised Dosages of TB Drugs for Children. Pediatr Infect Dis J 37:43-51
Lee, Hana; Wu, Xiaotian K; Genberg, Becky L et al. (2018) Beyond binary retention in HIV care: predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort. AIDS 32:2217-2225
Whiteley, Laura B; Brown, Larry K; Curtis, Virginia et al. (2018) Publicly Available Internet Content as a HIV/STI Prevention Intervention for Urban Youth. J Prim Prev :

Showing the most recent 10 out of 806 publications